Patients with primary aldosteronism appear to have a significantly higher prevalence of anxiety disorders compared to the general population.
Supports anxiety screening consideration in primary aldosteronism; leaves open causality and requires prospective confirmation.
The occurrence of anxiety disorders in patients with primary aldosteronism was much higher than that found in the general population and in primary care. Since an association between hyperaldosteronism and anxiety has also been suggested in previous animal studies, it seems worthwhile to gain further knowledge on clinical aspects by larger population studies.
No takes yet. Share an insight, caveat, or question.
Sonino et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: